Back to Search
Start Over
The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
- Source :
- Plant Methods, Plant Methods, BioMed Central, 2011, 6 (9), pp.e24369. ⟨10.1371/journal.pone.0024369⟩, PLoS ONE, PLoS ONE, Vol 6, Iss 9, p e24369 (2011)
- Publication Year :
- 2011
- Publisher :
- Public Library of Science (PLoS), 2011.
-
Abstract
- International audience; Progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are progressive disabling neurological conditions usually fatal within 10 years of onset. Little is known about the economic costs of these conditions. This paper reports service use and costs from France, Germany and the UK and identifies patient characteristics that are associated with cost. 767 patients were recruited, and 760 included in the study, from 44 centres as part of the NNIPPS trial. Service use during the previous six months was measured at entry to the study and costs calculated. Mean six-month costs were calculated for 742 patients. Data on patient sociodemographic and clinical characteristics were recorded and used in regression models to identify predictors of service costs and unpaid care costs (i.e., care from family and friends). The mean six-month service costs of PSP were €24,491 in France, €30,643 in Germany and €25,655 in the UK. The costs for MSA were €28,924, €25,645 and €19,103 respectively. Unpaid care accounted for 68-76%. Formal and unpaid costs were significantly higher the more severe the illness, as indicated by the Parkinson's Plus Symptom scale. There was a significant inverse relationship between service and unpaid care costs.
- Subjects :
- Male
MESH: Multiple System Atrophy
Anatomy and Physiology
Non-Clinical Medicine
Economics
D901 Europe (General)
lcsh:Medicine
Social and Behavioral Sciences
Severity of Illness Index
0302 clinical medicine
RA0421 Public health. Hygiene. Preventive Medicine
Germany
Economic cost
Epidemiology
030212 general & internal medicine
lcsh:Science
health care economics and organizations
MESH: Aged
Human Capital
MESH: Middle Aged
Multidisciplinary
MESH: Health Services
Neurodegenerative Diseases
Parkinson Disease
Health Services
Middle Aged
Socioeconomic Aspects of Health
Natural history
Neurology
RC0346
Scale (social sciences)
Medicine
MESH: Great Britain
Female
France
Supranuclear Palsy, Progressive
Public Health
Research Article
H Social Sciences (General)
medicine.medical_specialty
Neurological System
Progressive supranuclear palsy
03 medical and health sciences
Health Economics
Atrophy
MESH: Severity of Illness Index
Severity of illness
medicine
Humans
Psychiatry
Biology
MESH: Germany
Aged
Service (business)
Health Care Policy
MESH: Humans
business.industry
lcsh:R
Economics of Health
Multiple System Atrophy
medicine.disease
United Kingdom
MESH: Male
MESH: France
MESH: Supranuclear Palsy, Progressive
lcsh:Q
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Health Statistics
business
MESH: Female
030217 neurology & neurosurgery
Demography
Subjects
Details
- ISSN :
- 19326203 and 17464811
- Volume :
- 6
- Database :
- OpenAIRE
- Journal :
- PLoS ONE
- Accession number :
- edsair.doi.dedup.....60290ce5b1a1cfd1d68208aede7d50b5